Literature DB >> 34183334

Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.

Miriam Casey-Bryars1, John Griffin2, Conor McAloon3, Andrew Byrne4, Jamie Madden2, David Mc Evoy5, Áine Collins2, Kevin Hunt6, Ann Barber2, Francis Butler6, Elizabeth Ann Lane7, Kirsty O'Brien8, Patrick Wall9, Kieran Walsh8, Simon John More2.   

Abstract

OBJECTIVE: To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. SETTING/
DESIGN: Secondary analysis of international published data. DATA SOURCES: Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. PARTICIPANTS: Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020.
METHODS: Simulations were generated of incubation period and of serial interval or generation time. From these, transmission times relative to symptom onset, and the proportion of presymptomatic transmission, were estimated. OUTCOME MEASURES: Transmission time of SARS-CoV-2 relative to symptom onset and proportion of presymptomatic transmission.
RESULTS: Based on 18 serial interval/generation time estimates from 15 papers, mean transmission time relative to symptom onset ranged from -2.6 (95% CI -3.0 to -2.1) days before infector symptom onset to 1.4 (95% CI 1.0 to 1.8) days after symptom onset. The proportion of presymptomatic transmission ranged from 45.9% (95% CI 42.9% to 49.0%) to 69.1% (95% CI 66.2% to 71.9%).
CONCLUSIONS: There is substantial potential for presymptomatic transmission of SARS-CoV-2 across a range of different contexts. This highlights the need for rapid case detection, contact tracing and quarantine. The transmission patterns that we report reflect the combination of biological infectiousness and transmission opportunities which vary according to context. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; infection control; infectious diseases; public health; virology

Year:  2021        PMID: 34183334     DOI: 10.1136/bmjopen-2020-041240

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  12 in total

1.  Number Needed to Quarantine and Proportion of Prevented Infectious Days by Quarantine: Evaluating the Effectiveness of COVID-19 Contact Tracing.

Authors:  Diogo Fernandes da Silva; João Vasco Santos; Filipa Santos Martins
Journal:  Public Health Rep       Date:  2022-08-20       Impact factor: 3.117

2.  Inference of the SARS-CoV-2 generation time using UK household data.

Authors:  Sebastian Funk; Robin N Thompson; William S Hart; Sam Abbott; Akira Endo; Joel Hellewell; Elizabeth Miller; Nick Andrews; Philip K Maini
Journal:  Elife       Date:  2022-02-09       Impact factor: 8.713

3.  WHotLAMP: A simple, inexpensive, and sensitive molecular test for the detection of SARS-CoV-2 in saliva.

Authors:  David Ng; Ana Pinharanda; Merly C Vogt; Ashok Litwin-Kumar; Kyle Stearns; Urvashi Thopte; Enrico Cannavo; Armen Enikolopov; Felix Fiederling; Stylianos Kosmidis; Barbara Noro; Ines Rodrigues-Vaz; Hani Shayya; Peter Andolfatto; Darcy S Peterka; Tanya Tabachnik; Jeanine D'Armiento; Monica Goldklang; Andres Bendesky
Journal:  PLoS One       Date:  2021-09-16       Impact factor: 3.752

4.  A Telemedicine-Guided Self-Collection Approach for PCR-Based SARS-CoV-2 Testing: Comparative Study.

Authors:  Silvia Würstle; Johanna Erber; Michael Laxy; Christoph D Spinner; Michael Hanselmann; Dieter Hoffmann; Stanislas Werfel; Svenja Hering; Simon Weidlich; Jochen Schneider; Ralf Franke; Michael Maier; Andreas G Henkel; Roland M Schmid; Ulrike Protzer
Journal:  JMIR Form Res       Date:  2022-01-04

Review 5.  Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States.

Authors:  Radhika Gharpure; Samira Sami; Johanna Vostok; Hillary Johnson; Noemi Hall; Anne Foreman; Rebecca T Sabo; Petra L Schubert; Hanna Shephard; Vance R Brown; Ben Brumfield; Jessica N Ricaldi; Andrew B Conley; Lindsay Zielinski; Lenka Malec; Alexandra P Newman; Michelle Chang; Lauren E Finn; Cameron Stainken; Anil T Mangla; Patrick Eteme; Morgan Wieck; Alison Green; Alexandra Edmundson; Diana Reichbind; Vernell Brown; Laura Quiñones; Allison Longenberger; Elke Hess; Megan Gumke; Alicia Manion; Hannah Thomas; Carla A Barrios; Adrianna Koczwara; Thelonious W Williams; Marcia Pearlowitz; Moussokoura Assoumou; Alessandra F Senisse Pajares; Hope Dishman; Cody Schardin; Xiong Wang; Kendalyn Stephens; Nakema S Moss; Gurpalik Singh; Christine Feaster; Lindsey Martin Webb; Anna Krueger; Kristen Dickerson; Courtney Dewart; Bree Barbeau; Amelia Salmanson; Lawrence C Madoff; Julie M Villanueva; Catherine M Brown; A Scott Laney
Journal:  Emerg Infect Dis       Date:  2021-11-18       Impact factor: 6.883

6.  Rapid antigen testing for SARS-CoV-2 infection in a university setting in Ireland: Learning from a 6-week pilot study.

Authors:  Gerald Barry; Catherine McCarney; Marc Farrelly; Rory Breathnach; Carmel Mooney; Simon J More
Journal:  Public Health Pract (Oxf)       Date:  2022-04-03

7.  Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan.

Authors:  Tsuyoshi Ogata; Hideo Tanaka; Fujiko Irie; Atsushi Hirayama; Yuki Takahashi
Journal:  Int J Environ Res Public Health       Date:  2022-01-20       Impact factor: 3.390

8.  Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions and testing.

Authors:  Yael Gurevich; Yoav Ram; Lilach Hadany
Journal:  Evol Med Public Health       Date:  2022-04-18

9.  Dispersion of SARS-CoV-2 in air surrounding COVID-19-infected individuals with mild symptoms.

Authors:  Jostein Gohli; Ane Marie Anderson; Arne Broch Brantsaeter; Kari Oline Bøifot; Carola Grub; Cathrine Lund Hadley; Andreas Lind; Ellen Susanne Pettersen; Arne Vasli Lund Søraas; Marius Dybwad
Journal:  Indoor Air       Date:  2022-02       Impact factor: 6.554

10.  Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.

Authors:  Seran Hakki; Jie Zhou; Jakob Jonnerby; Anika Singanayagam; Jack L Barnett; Kieran J Madon; Aleksandra Koycheva; Christine Kelly; Hamish Houston; Sean Nevin; Joe Fenn; Rhia Kundu; Michael A Crone; Shazaad Ahmad; Nieves Derqui-Fernandez; Emily Conibear; Paul S Freemont; Graham P Taylor; Neil Ferguson; Maria Zambon; Wendy S Barclay; Jake Dunning; Ajit Lalvani
Journal:  Lancet Respir Med       Date:  2022-08-18       Impact factor: 102.642

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.